What is the recommended protamine sulfate dose for reversing unfractionated heparin and low‑molecular‑weight heparin, including maximum dose and adjustments for protamine allergy?

Protamine Dose for Heparin Reversal

For unfractionated heparin (UFH), administer protamine sulfate at 1 mg per 100 units of heparin given in the previous 2-3 hours, with a maximum single dose of 50 mg. 1

Unfractionated Heparin Reversal

Initial Dosing

• Calculate based on recent heparin exposure: 1 mg protamine neutralizes approximately 100 units of UFH 1, 2, 3
• Time-dependent dosing: Only account for heparin administered in the preceding 2-3 hours due to UFH's short half-life (60-120 minutes) 1, 4
• Maximum single dose: 50 mg protamine 1, 2
• Administration: Slow IV infusion over 10 minutes to minimize hypotension, bradycardia, and anaphylaxis risk 1, 2

Repeat Dosing if Needed

If aPTT remains elevated after initial protamine administration, give 0.5 mg protamine per 100 units of UFH 1

Time-Adjusted Dosing

The protamine dose decreases as time elapses from heparin administration:

• 30 minutes post-heparin: One-half the usual dose may suffice 2
• This reflects UFH's rapid clearance from circulation 2, 3

Low-Molecular-Weight Heparin (LMWH) Reversal

Enoxaparin-Specific Dosing

• Within 8 hours: 1 mg protamine per 1 mg enoxaparin (maximum 50 mg single dose) 1
• 8-12 hours: 0.5 mg protamine per 1 mg enoxaparin 1
• Beyond 12 hours: Protamine likely unnecessary after 3-5 half-lives 1

Other LMWHs (Dalteparin, Nadroparin, Tinzaparin)

• Dose: 1 mg protamine per 100 anti-Xa units of LMWH administered within 3-5 half-lives 1
• Maximum: 50 mg single dose 1

Repeat LMWH Dosing

For life-threatening bleeding or renal insufficiency: 0.5 mg protamine per 100 anti-Xa units or per 1 mg enoxaparin 1

Critical Dosing Considerations

Maximum Dose Limitation

The 50 mg maximum single dose is a strong recommendation with moderate quality evidence 1. This limit prevents protamine-related complications including:

• Hypotension and bradycardia 4, 2
• Anaphylactoid reactions 2, 3
• Paradoxical anticoagulation from protamine excess 4, 2

Protamine's Limitations with LMWH

Protamine only partially reverses LMWH anticoagulation 4, 5:

• Neutralizes 100% of anti-IIa activity but only 50-60% of anti-Xa activity 4
• Effectiveness varies by LMWH type: >80% for tinzaparin, 75% for dalteparin, 50% for enoxaparin/nadroparin 4

Monitoring After Reversal

• Check aPTT or anti-Xa 15-30 minutes post-protamine to assess adequacy 4
• Rebound anticoagulation possible: Protamine's half-life (7 minutes) is shorter than heparin's, potentially requiring repeat dosing 4

Special Populations and Situations

Renal Insufficiency

• LMWH accumulates in renal failure (CrCl <30 mL/min) 6, 7
• Consider protamine even beyond typical timeframes if anti-Xa remains elevated 7
• Monitor anti-Xa levels to guide dosing 7

Prophylactic Heparin

• Do not routinely reverse prophylactic subcutaneous heparin 1
• Consider reversal only if aPTT significantly prolonged 1

Protamine Allergy Risk Factors

Patients at increased risk include those with 4:

• Previous protamine exposure
• NPH insulin use (contains protamine)
• Fish allergies
• Post-vasectomy or sterility (anti-protamine antibodies)

Management: Have resuscitation equipment immediately available; administer slowly over 10 minutes 4, 2

Agents NOT Reversed by Protamine

Do not use protamine for 1:

• Pentasaccharides (fondaparinux) - use aPCC 20 IU/kg or rFVIIa 90 μg/kg instead
• Direct thrombin inhibitors (dabigatran, argatroban, lepirudin)
• Direct factor Xa inhibitors (apixaban, rivaroxaban, edoxaban)

Practical Algorithm

1. Identify heparin type and timing: UFH vs LMWH, time since last dose
2. Calculate protamine dose based on guidelines above
3. Never exceed 50 mg single dose
4. Administer slowly IV over 10 minutes
5. Recheck aPTT or anti-Xa at 15-30 minutes
6. Redose at half-strength if inadequate reversal
7. Monitor for rebound anticoagulation, especially with subcutaneous heparin

The 2016 Neurocritical Care Society/Society of Critical Care Medicine guidelines provide the most comprehensive, evidence-based recommendations for protamine dosing across clinical scenarios 1. Recent research suggests even lower protamine:heparin ratios (0.5:1 to 0.625:1) may be adequate for UFH reversal 8, 9, though these findings require prospective validation before changing established practice.